3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
23
Phase 3
13
Phase 1/2
13
Phase 1
13
Phase NA
1
Phase 4
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
4
Breast
3
Other hematologic neoplasm
2
Myeloid
2
Thoracic
1
Other solid neoplasm
1
NET
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Conditions
Thoracic Neoplasms
1
Interventions
Pemetrexed
23
Carboplatin
21
Cisplatin
20
pembrolizumab
15
Docetaxel
14
Paclitaxel
10
Gemcitabine
8
Drug Therapy
7
Bevacizumab
7
Gefitinib
5
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Erlotinib Hydrochloride
4
130-nm albumin-bound paclitaxel
4
cemiplimab
3
atezolizumab
3
anlotinib
3
Dexamethasone
3
dexamethasone acetate
2
dexamethasone 21-phosphate
2
cobimetinib
2
auricularum
2
aumolertinib
2
apatinib
2
Vemurafenib
2
Topotecan
2
Temozolomide
2
Surgical Procedures, Operative
2
Standard of Care
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Injections
×
Thoracic
×
Clear all
NCT04209868
2024-03-29
ParaSOL
Guy's and St Thomas' NHS Foundation Trust
Phase 2/3
Unknown
100 enrolled